![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
International Biotechnology Trust Plc | LSE:IBT | London | Ordinary Share | GB0004559349 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
8.00 | 1.14% | 708.00 | 714.00 | 716.00 | 720.00 | 706.00 | 706.00 | 132,379 | 16:35:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 12.06M | 6.81M | 0.1835 | 38.91 | 259.91M |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")
Latest Factsheet and Blog
IBT's factsheet for the month ended 30 April 2024 is now available directly via its web page. Please click here, then 'latest factsheet'.
IBT recently celebrated its 30-year anniversary, having launched as a pioneering investment trust dedicated to the nascent opportunity in biotech back in 1994. In the latest blog post, Marking IBT's 30-year anniversary with a look at the transformation of cancer therapy, Fund Managers Ailsa Craig and Marek Poszepczynski explore the key developments in cancer treatment during this time and the outlook for future breakthroughs, which are collectively profoundly changing the prospects for many patients.
The blog can be read here: https://www.schroders.com/en-gb/uk/individual/content/marking-ibt-s-30-year-anniversary-with-a-look-at-the-transformation-of-cancer-therapy/
To sign up for IBT updates by email, please click here.
ENDS
Enquiries:
Schroder Investment Management Limited
Augustine Chipungu (Press) Kirsty Preston
Kerry Higgins (Company Secretary) |
020 7658 6000
020 7658 6000
|
|
Kaso Legg Communications (Financial PR)
Charles Gorman Henry Taylor Effie Aye Maung Hider
|
|
|
1 Year International Biotechnol... Chart |
1 Month International Biotechnol... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions